Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Myeloma
Related studies linked through entity extraction aliases.
VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Imaging Study of Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis?
- Status
- TERMINATED
- Phase
- N/A
Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Machine Learning in Myeloma Response
- Status
- UNKNOWN
- Phase
- NA
WB-EMS and Nutrition in Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- NA
PET Imaging of Subjects Using 124I-PU-AD
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
- Status
- UNKNOWN
- Phase
- NA
Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Pedometer Activity Monitoring After ASCT
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Bergamo Lymphoid Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
Mobile Health Device Study for Myeloma Patients
- Status
- COMPLETED
- Phase
- N/A
Changing Over Time of Ascorbic Acid After Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A